现在位置:医学图书 > 首页 > 医学图书 > 医学 > 药学 > 药学理论 图书编号:10838
 
《医药化学》
作者:(英)帕特里克(Patrick,G.) 著
出版社:科学出版社 出版日期:2003-4-1
ISBN:7030109627 定价:32元
    内容提要

    “精要速览系列(Instant Notes Series)”丛书是国外教材“Best Seller”榜的上榜教材。该系列结构新颖,视角独特;重点明确,脉络分明;图表简明清晰;英文自然易懂,被国内多所重点院校选用作为双语教材。先锋版是继“现代生物学精要速览”之后推出的跨学科的升级版本。

    本书是该系列中的《医药化学》分册,全书共13章,综合了化学、生物学和计算机科学的内容,扼要介绍了药物设计与发现、新药开发与应用、临床试验及专利申请等。

    本书是指导大学生快速掌握医药化学基础知识的优秀教材,也是辅助教师授课的极佳教学参考书,同时可供相关专业的研究生参考。

    目录

    Abbreviations

    Preface

    About the author

    Section A-The science of medicinal chemistry

    A1 Introduction

    A2 From concept to market

    Section B-Drug targets

    B1 Enzymes

    B2 Receptors

    B3 Carrier proteins

    B4 Structural proteins

    B5 Nucleic acids

    B6 Lipids

    B7 Carbohydrates

    Section C-Pharmacokinetics

    C1 Pharmacokinetics

    C2 Drug absorption

    C3 Drug distribution

    C4 Drug metabolism

    C5 Drug excretion

    C6 Drug administration

    C7 Drug dosing

    Section D-Biological testing and bioassays

    D1 Testing drugs

    D2 Testing drugs in uitro

    D3 Testing drugs in uiuo

    Section E-Drug discovery

    E1 The lead compound

    E2 Natural sources of lead compounds

    E3 Synthetic sources of lead compounds

    Section F-Synthesis

    F1 Synthetic considerations

    F2 Stereochemistry

    F3 Combinatorial synthesis

    Section G-Structure-activity relationships

    G1 Definition of structure-activity relationshiips

    G2 Binding interactions

    G3 Functional groups as binding groups

    G4 The pharmacophore

    G5 Quantitative structure-activity relationships

    Section H-Target orientated drug design

    H1 Aims of drug design

    H2 Computer aided drug design

    H3 Simplification of complex molecules

    H4 Conformational restraint

    H5 Extra binding interactions

    H6 Enhancing existing binding interactions

    Section I-Pharmacokinetic orientated drug design

    I1 Drug solubility

    I2 Drug stability

    Section J-Patenting and manufacture

    J1 Patenting and chemical development

    J2 Optimization of reactions

    J3 Scale-up issues

    J4 Process development

    J5 Specifications

    Section K-Preclinical testing and clinical trials

    K1 Toxicology

    K2 Pharmacology and pharamceutical chemistry

    K3 Drug metabolism studies

    K4 Clinical trials

    K5 Regulatory affairs

    Section L-Case study:inhibitors of EGF-receptor kinase

    L1 Epidermal growth factor receptor

    L2 Testing procedures

    L3 From lead compound to dianilino-phthalimides

    L4 Modeling studies

    L5 4-(Phenylamino)pyrrolopyrimidines

    L6 Pyrazolopyrimidines

    Section M-History of medicinal chemistry

    M1 The age of herbs,potions and magic

    M2 The nineteenth century

    M3 A fledgling science(1900-1930)

    M4 The dawn of the antibacterial age(1930-1945)

    M5 The antibiotic age(1945-1970s)

    M6 The age of reason (1970s to present)

    Further reading

    Index